腫瘍 が 退去 し て も 損傷 が 残っ て いる 時:パラガングリオマ の 切除 後 の 心筋 病 症 の 回復 が 遅い 場合
Josephine Ria Pitasari1, Sajjad Gul2, Jerry Kenmoe1
1Department of Internal Medicine, McLaren Health Care/Michigan State University, Flint, MI, USA.
Journal of medical cases
|September 4, 2025
まとめ
パラガングリオマは カテコアミン誘発性心筋病を 引き起こす可能性があります 手術後の回復は様々で,一部の患者は改善が遅れており,高血圧などのリスクが持続します.
科学分野:
- 心臓病科
- 内分泌学
- 腫瘍学
背景:
- パラガンジロマによるカテコアミン誘発性心筋病は稀だが,回復可能である.
- パラガングリオマ切除後の回復は変動し,遅れる可能性があります.
- 腎上腺外パラガンリオマは重度の心臓および多臓器機能不全を引き起こす可能性があります.
研究 の 目的:
- パラガンジロマによる カテコアミン誘発性心筋不全の症例です
- 切開後の可変回復経路と持続的な心血管リスクを示すために.
- 多分野での管理と心臓の監視の必要性を強調する.
主な方法:
- 47歳の男性 エクストラ・アドレナ・パラガンリオマ
- エコーカーディオグラフィによる左心室放出分数 (LVEF) の評価.
- 手術後の血圧と神経状態のモニタリング
主要な成果:
- 急性不補償性心不全 (LVEF 30~35%) と多臓器機能障害を有する患者.
- 切開後2週間でLVEFは45%に改善したが,高血圧は持続した.
- 患者は,生化学療法によって治癒したにもかかわらず,一時的な血栓梗塞 (TIA) を経験した.
結論:
- パラガンジロマによる心筋病の回復は,成功した切除後でも変動します.
- 持続的なリスクには,耐性高血圧と脳血管疾患が含まれます.
- 継続的な心臓モニタリングと多科目の治療は特に社会経済的な障壁を持つ患者にとって重要です.
関連する概念動画
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:29Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:29Cardiomyopathy VI: Nursing Management
30
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
30
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
25
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
25